Zepbound Outperforms CagriSema in Head to Head Phase III Obesity Trial PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased Cagrilintide Dosage Calculator and Chart Cagrilintide and semaglutide together drive record weight loss in global trial